Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock price Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | +1.01% | +0.50% | -2.90% |
Sales 2023 * | 8.55B 1.18B | Sales 2024 * | 9.64B 1.33B | Capitalization | 18.94B 2.62B |
---|---|---|---|---|---|
Net income 2023 * | 1.08B 150M | Net income 2024 * | 1.28B 177M | EV / Sales 2023 * | 2.22 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 1.97 x |
P/E ratio 2023 * |
20
x | P/E ratio 2024 * |
16.9
x | Employees | 4,913 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 31.62% |
1 day | +1.01% | ||
1 week | +0.50% | ||
Current month | +2.55% | ||
1 month | +3.08% | ||
3 months | -1.47% | ||
6 months | +7.49% | ||
Current year | -2.90% |
Managers | Title | Age | Since |
---|---|---|---|
Lei Wang
CEO | Chief Executive Officer | 53 | 22-08-21 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
42 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Zhang
BRD | Director/Board Member | 55 | 19-09-29 |
Yoke Pheng Liew
BRD | Director/Board Member | 68 | 20-06-04 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 54 | 12-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.01 | +1.01% | 207 500 |
24-03-27 | 1.99 | +2.05% | 127,300 |
24-03-26 | 1.95 | -3.47% | 162,000 |
24-03-25 | 2.02 | +3.59% | 121,900 |
24-03-22 | 1.95 | -2.01% | 70,100 |
Delayed Quote Singapore S.E., March 28, 2024 at 04:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.32% | 5.39B | |
-12.48% | 4.67B | |
-6.70% | 3.29B | |
-2.41% | 2.52B | |
-7.97% | 1.7B | |
+24.37% | 1.63B | |
-8.02% | 1.61B | |
-4.40% | 1.56B | |
-8.51% | 1.41B |
- Stock
- Equities
- Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited - Singapore S.E.